#pharmaceutical-economics

[ follow ]
Coronavirus
fromwww.theguardian.com
1 month ago

HIV-ending' drug could be made for just $25 per patient a year, say researchers

Lenacapavir could drastically reduce HIV infections if priced affordably, as it could be produced for just $25 a year.
[ Load more ]